EDWARD HURWITZ

Profile

First Name

: EDWARD

Middle Name

:

Last Name

: HURWITZ

Related Companies
Titles
Company Name
Related People
DIRECTOR
CALISTOGA PHARMACEUTICALS INC
AARON COE, ROBERT LEE DOUGLAS, CAROL GALLAGHER, W. MICHAEL GALLATIN, W. MICHAEL GALLATIN, ANDREW GUGGENHIME, ED HURWITZ, RICHARD LIN, LANGDON MILLER, CLIFFORD STOCKS, JAMES TOPPER
DIRECTOR
APPLIED GENETIC TECHNOLOGIES CORP
KENT GOSSETT, SCOTT KOENIG, GARHENG KONG, NICHOLAS MUZYCZKA, ARNOLD ORONSKY, JAMES ROSEN, FRANK TOP, SUSAN B WASHER, SAM WU, SAMUEL WU
DIRECTOR
PROTEGO BIOPHARMA
SAOUSSEN BEN HALIMA, LAURA BRASS, SHELLEY CHU, XIN JIANG, JEFFERY KELLY, JEFFERY W KELLY, JEFFREY KELLY, HELEN KIM, RICHARD LABAUDINIERE, TIM LOHOFF, JANWILLEM NAESENS, HANK MICHAEL PETRASSI, BRENT J. WARNER
DIRECTOR
RECODE THERAPEUTICS, INC.
RANA AL-HALLAQ, ALAN COLOWICK, RAKHSHITA DHAR, JULIA EASTLAND, KOUKI HARASAKI, ARTHUR E JOHNSON, HELEN KIM, HELEN S. KIM, DAVID LOCKHART, DAVID J LOCKHART, DAVID J. LOCKHART, PATRICIA MILLICAN, TRISHA MILLICAN, DEAN MITCHELL, OLEG NODELMAN, INAI PARK, RA SESSION II, SHEHNAAZ SULIMAN, PETER THOMPSON, PETER A. THOMPSON, MICHAEL TORRES, BASHEER ZADA
DIRECTOR
DYNE THERAPEUTICS, INC.
OXANA BESKROVNAYA, PH.D., JOSHUA BRUMM, DIRK KERSTEN, LAWRENCE KLEIN, PH.D., DAVID LUBNER, JONATHAN MCNEILL, M.D., JASON RHODES, RICHARD SCALZO, CATHERINE STEHMAN-BREEN, M.D., ROMESH SUBRAMANIAN, PH.D.
DIRECTOR
PROTEGO BIOPHARMA, INC.
SAOUSSEN BEN HALIMA, LAURA BRASS, SHELLEY CHU, XIN JIANG, JEFFERY KELLY, JEFFERY W KELLY, JEFFREY KELLY, HELEN KIM, RICHARD LABAUDINIERE, TIM LOHOFF, JANWILLEM NAESENS, HANK MICHAEL PETRASSI, BRENT J. WARNER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-12-03
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2025-10-17 
2025-10-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2025-09-23 
2023-09-28
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-10-13 
2023-01-27
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2021-10-13 
2022-07-06
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-10-13 
2021-10-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-10-19 
2021-10-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-10-13 
2020-08-14
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-08-07 
2020-03-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-03-06 
2019-12-17
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2019-12-06 
2012-11-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-11-15 
2010-12-27
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-06-29 
2010-07-02
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-06-29